Safety and immunogenicity of rabies pre- and postexposure intradermal regimens using Abhayrab, a purified vero cell rabies vaccine (PVRV) produced in India in healthy volunteers: towards greater affordability of rabies prophylaxis
References
- 1. PSMD Task Force Recommendation for Rabies Pre and Post exposure prophylaxis, Phil J Microbiol Infect Dis. 1997, 26:25-9.
- 2. WHO Expert Committee on Rabies, 8th report, TRS 824, World Health Organization, Geneva, 1992.
- 3. World Health Organization, Report of a WHO consultation on intradermal application of human rabies vaccines, Geneva, 13-14 March 1995.
- 4. Matha IS, Salunke SR. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India, CID. 2005; 40:611-3.
- 5. Sampath G, Sangram P, Ananda MN, Udaya Bhaskar RY, Palaniappan C, Suhasini RV. Clinical study to assess the safety and immunogenicity of vero cell culture inactivated rabies vaccine, Journal of APCRI (Assoc Prevent Contral Rabies India). 2000; 1:50-2.
- 6. Sampath G, Suhasini RV, Lakshmi PR, Udayabhaskara RY, Palaniappan C. An immunogenicity study of a newly introduced purified vero cell rabies vaccine (Abhayrab) manufactured in India. Vaccine. 2005; 23: 897-900.10.1016/j.vaccine.2004.08.001
- 7. Kempegowda Institute of Medical Sciences. A Guide to Intradermal Rabies Vaccination. Bangalore, India: Website: www.kimscommunitymedicine.org,2006.
- 8. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. Geneva: WHO, 1997.
- 9.Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. National Center for Immunization and Respiratory Diseases: Basics and Common Questions- Possible Side-effects from Vaccines, http://www.cdc.gov/vaccines/vac-gen'side-effects.htm*rrabies, 2007.
- 10. Indian Council of Medical Research. India http://icmr.me.mannual'2004-05/nie/clinical_tnals.pdf
- 11. Meslin F-X. The challenge to provide affordable rabies post-exposure treatment: Vaccine. 2003; 21: 4122-3.10.1016/S0264-410X(03)00393-1
- 12. Briggs BJ. Banjhoff A, Nicolay U, Sinlkwin S. Dumavibhat B. Tongswas S, et al. Antibody- response of patients after post exposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine. Bull World Health Organization. 2000; 78:693-8.
- 13. Warrell M J. Riddel A, Yu L-M Phipps J. Diggle L. Bourhy H, et al. Simplified 4-site economical mtradennal post-exposure rabies vaccine regimen: a randomized controlled comparison with standard methods. Trop Dis. 2008; 2: e224.
- 14. Nirmal S. Cherian T, Samuel BU. Rajasingh J, Raghupathy P. John TJ. Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine. Vaccine. 1998; 16: 928-31.10.1016/S0264-410X(97)00293-4
- 15. Belshe RB. Newman FK. Cannon J. Duane C , Treanor J. Van Hoecke C. et al. Serum antibody responses after intradeimal vaccination against influenza. N Engl JMed. 2004;351:2286-94.
- 16. Kenney RT. Freeh SA. Muenz LR. Villar CP. Glenn GM. Dose sparing with intradeimal injection of influenza vaccine. NEngl JMed. 2004; 351:2295-301.
- 17. Ghabouli MJ. Sabouri AH, Shoeibi N. Bajestan SN, Bara daran H. Mohammad JG et al. High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination. Eur J Epidemiol. 2004; 19:871-5.
- 18. Whittle HC. Lamb WH, Ryder RW. Trials of mtradennal hepatitis B vaccines in Gambian children. Ann Trop Paediatr. 1987; 7:6-9.
Language: English
Page range: 61 - 67
Published on: Apr 13, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 times per year
Keywords:
Related subjects:
© 2018 Rio L. Magpantay, Nancy Bermal, Plebeian Medina, Beatriz P. Quiambao, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.